La Jolla Pharmaceutical Co insider trades: Tetraphase Pharmaceuticals (TTPH) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where La Jolla Pharmaceutical Co reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 28, 2020 | TTPH | ↑ Buy | 3,737,360 | $2.00 | $7.5M | See Explanation of Responses | Jul 29, 2020 (1d) |
| Jun 19, 2020 | TTPH | ↑ Buy | 234,698 | $2.62 | $614K | Direct | Jun 22, 2020 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About La Jolla Pharmaceutical Co's insider trades
La Jolla Pharmaceutical Co is a 10% owner of Tetraphase Pharmaceuticals (TTPH). Since Jun 19, 2020, it has reported 2 open-market purchases worth $8.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TTPH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.